190 related articles for article (PubMed ID: 34287856)
1. Association of Parenteral Anticoagulation Therapy With Outcomes in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Without Invasive Therapy: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project.
Liu YH; Fan HL; Zeng LH; Duan CY; Chen G; Chen PY; Zhao D; Liu J; Hao YC; He WF; Tao S; Wei XB; Jiang L; Guo W; Guo YS; Chen W; Li J; Hu YZ; Li WS; Chen YY; Luo JF; Zhou YL; Yu DQ; Han YL; Tan N; Chen JY; He PC
Clin Pharmacol Ther; 2021 Oct; 110(4):1119-1126. PubMed ID: 34287856
[TBL] [Abstract][Full Text] [Related]
2. Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome.
Chen JY; He PC; Liu YH; Wei XB; Jiang L; Guo W; Duan CY; Guo YS; Yu XP; Li J; Li WS; Zhou YL; Lin CY; Luo JF; Yu DQ; Chen ZJ; Chen W; Chen YY; Guo ZQ; Geng QS; Tan N
JAMA Intern Med; 2019 Feb; 179(2):186-194. PubMed ID: 30592483
[TBL] [Abstract][Full Text] [Related]
3. Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China).
Yang Q; Wang Y; Liu J; Liu J; Hao Y; Smith SC; Huo Y; Fonarow GC; Ma C; Ge J; Taubert KA; Morgan L; Guo Y; Wang W; Zhou Y; Zhao D;
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28606999
[TBL] [Abstract][Full Text] [Related]
4. Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
Cornel JH; Ohman EM; Neely B; Jakubowski JA; Bhatt DL; White HD; Ardissino D; Fox KA; Prabhakaran D; Armstrong PW; Erlinge D; Tantry US; Gurbel PA; Roe MT
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27815268
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis.
Galli M; Andreotti F; D'Amario D; Vergallo R; Vescovo GM; Giraldi L; Migliaro S; Ameri P; Porto I; Crea F
Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):43-56. PubMed ID: 31350546
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation with otamixaban and ischemic events in non-ST-segment elevation acute coronary syndromes: the TAO randomized clinical trial.
Steg PG; Mehta SR; Pollack CV; Bode C; Cohen M; French WJ; Hoekstra J; Rao SV; Ruzyllo W; Ruiz-Nodar JM; Sabaté M; Widimsky P; Kiss RG; Navarro Estrada JL; Hod H; Kerkar P; Guneri S; Sezer M; Ruda M; Nicolau JC; Cavallini C; Ebrahim I; Petrov I; Kim JH; Jeong MH; Ramos Lopez GA; Laanmets P; Kovar F; Gaudin C; Fanouillere KC; Minini P; Hoffman EB; Moryusef A; Wiviott SD; Sabatine MS;
JAMA; 2013 Sep; 310(11):1145-55. PubMed ID: 23995608
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR Study.
Stepinska J; Wojtkowska I; Annemans L; Danchin N; Pocock SJ; de Werf FV; Medina J; Bueno H
Curr Vasc Pharmacol; 2020; 18(1):92-99. PubMed ID: 30588886
[TBL] [Abstract][Full Text] [Related]
8. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non-ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy.
Porto I; Bolognese L; Dudek D; Goldstein P; Hamm C; Tanguay JF; Ten Berg J; Widimský P; Le Gall N; Zagar AJ; LeNarz LA; Miller D; Montalescot G;
JACC Cardiovasc Interv; 2016 May; 9(9):897-907. PubMed ID: 27151605
[TBL] [Abstract][Full Text] [Related]
9. Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial.
Dillinger JG; Ducrocq G; Elbez Y; Cohen M; Bode C; Pollack C; Nicolau JC; Henry P; Kedev S; Wiviott SD; Sabatine MS; Mehta SR; Steg PG
Circ Cardiovasc Interv; 2018 Jun; 11(6):e006084. PubMed ID: 29895599
[TBL] [Abstract][Full Text] [Related]
10. In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project.
Zhao G; Zhou M; Ma C; Huo Y; Smith SC; Fonarow GC; Ge J; Han Y; Liu J; Hao Y; Liu J; Wang X; Taubert KA; Morgan L; Zhao D; Nie S;
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29602767
[TBL] [Abstract][Full Text] [Related]
11. Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinux.
Steg PG; Mehta S; Jolly S; Xavier D; Rupprecht HJ; Lopez-Sendon JL; Chrolavicius S; Rao SV; Granger CB; Pogue J; Laing S; Yusuf S
Am Heart J; 2010 Dec; 160(6):1029-34, 1034.e1. PubMed ID: 21146654
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.
Marquis-Gravel G; Neely ML; Valgimigli M; Costa F; Van Klaveren D; Altner R; Bhatt DL; Armstrong PW; Fox KAA; White HD; Ohman EM; Roe MT
Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006582. PubMed ID: 32862694
[TBL] [Abstract][Full Text] [Related]
13. Impact of fondaparinux versus enoxaparin on in-hospital bleeding and 1-year death in non-ST-segment elevation myocardial infarction. FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) 2010.
Puymirat E; Schiele F; Ennezat PV; Coste P; Collet JP; Bonnefoy-Cudraz E; Roul G; Richard P; Simon T; Danchin N
Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):211-9. PubMed ID: 25075006
[TBL] [Abstract][Full Text] [Related]
14. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.
Alexander KP; Chen AY; Roe MT; Newby LK; Gibson CM; Allen-LaPointe NM; Pollack C; Gibler WB; Ohman EM; Peterson ED;
JAMA; 2005 Dec; 294(24):3108-16. PubMed ID: 16380591
[TBL] [Abstract][Full Text] [Related]
15. Optimizing antithrombotic therapy in patients with non-ST-segment elevation acute coronary syndrome.
Dobesh PP; Phillips KW; Haines ST
Am J Health Syst Pharm; 2008 Aug; 65(15 Suppl 7):S22-8. PubMed ID: 18653821
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, clinical determinants and prognostic implications of coronary procedural complications of percutaneous coronary intervention in non-ST-segment elevation myocardial infarction: Insights from the contemporary multinational TAO trial.
Abtan J; Wiviott SD; Sorbets E; Popovic B; Elbez Y; Mehta SR; Sabatine MS; Bode C; Pollack CV; Cohen M; Moccetti T; Laanmets P; Faxon D; Okreglicki A; Ducrocq G; Steg PG;
Arch Cardiovasc Dis; 2021 Mar; 114(3):187-196. PubMed ID: 33518473
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial).
Hinohara TT; Roe MT; White HD; Fox KAA; Bhatt DL; Hamm C; Gurbel PA; Aylward PE; Wiviott SD; Huber K; Neely ML; Ohman EM
Am J Cardiol; 2018 Oct; 122(8):1322-1329. PubMed ID: 30135019
[TBL] [Abstract][Full Text] [Related]
18. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.
Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J
Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731
[TBL] [Abstract][Full Text] [Related]
19. Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial).
Alkhalfan F; Nafee T; Yee MK; Chi G; Kalayci A; Plotnikov A; Braunwald E; Gibson CM
Am J Cardiol; 2020 Mar; 125(5):661-669. PubMed ID: 31898965
[TBL] [Abstract][Full Text] [Related]
20. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
